Mefoxin In Dextrose 5% In Plastic Container

   
Google
 
Web NewDrugInformation.com

Mefoxin In Dextrose 5% In Plastic Container


Drug - Mefoxin In Dextrose 5% In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefoxitin Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 40MG BASE/ML
The potency of the active ingredient(s), Cefoxitin Sodium. May repeat for multiple part products.

Applicant - MERCK
The firm name holding legal responsibility for Mefoxin In Dextrose 5% In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050581
The FDA assigned number to Mefoxin In Dextrose 5% In Plastic Container. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Mefoxin In Dextrose 5% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 20, 1984
The date Mefoxin In Dextrose 5% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Mefoxin In Dextrose 5% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Mefoxin In Dextrose 5% In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merck And Co Inc
The full name of the firm holding legal responsibility for the new application of Mefoxin In Dextrose 5% In Plastic Container.

Mefoxin In Dextrose 5% In Plastic Container